Allotment of 22,44,000 Equity Shares pursuant to the conversion of 22,44,000 convertible warrants ( Out of a total 5,80,32,500 Convertible warrants) to the allottee(s) belonging to the ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dipna Pharmachem has allotted 22,44,000 fully paid-up equity shares to two non-promoter allottees, Mr. Ashok Dilipkumar Jain and Ms. Kajal Ashok Jain, after they exercised their option to convert an equivalent number of convertible warrants. The shares were issued at Rs. 13.05 each (face value Rs. 10 plus Rs. 3.05 premium), with the company receiving the remaining 75% of the exercise price totalling about Rs. 2.20 crore in cash. This conversion is part of a larger pool of 5,80,32,500 convertible warrants issued earlier in September 2025, of which only 22,44,000 have been converted so far. As a result, the company's paid-up share capital has risen from Rs. 24.05 crore (2.40 crore shares) to Rs. 26.29 crore (2.63 crore shares). Post-allotment, the two allottees together hold about 8.54% of the expanded equity base.
This is a minor dilution event tied to a previously approved preferential warrant issue; share count rose by about 9.3% but only a small portion of the total warrants have been converted so far, so further dilution remains possible if the remaining warrants are exercised.